TABLE 4

Tumor, Kidney, and Stomach Uptake of 3 Investigated Radiotracers Without or With Phosphoramidon or Thiorphan in Nude Mice Bearing A431-CCK2R(+) and MZ-CRC-1 Xenografts

RadiotracerControl+ PhosphoramidonP+ ThiorphanP
177Lu-DOTA-MG11
 A431-CCK2R(+)1.45 ± 0.307.34 ± 1.64<0.00015.38 ± 1.36<0.0001
 MZ-CRC-13.17 ± 1.4717.24 ± 4.81<0.000112.41 ± 4.200.0007
 Kidneys1.08 ± 0.151.36 ± 0.240.00561.33 ± 0.410.1465
 Stomach1.06 ± 0.234.04 ± 0.74<0.00013.05 ± 0.83<0.0001
177Lu-DOTA-PP-F11
 A431-CCK2R(+)6.70 ± 0.569.34 ± 1.110.00148.68 ± 1.180.0096
 MZ-CRC-111.16 ± 2.9419.72 ± 4.680.00858.09 ± 2.170.1905*
 Kidneys4.30 ± 0.565.50 ± 0.770.00086.56 ± 0.86<0.0001*
 Stomach2.18 ± 0.951.72 ± 0.220.32272.20 ± 0.390.9628
177Lu-DOTA-PP-F11N
 A431-CCK2R(+)6.94 ± 0.828.53 ± 2.220.085510.01 ± 2.780.0114
 MZ-CRC-120.68 ± 1.7115.56 ± 3.800.021521.82 ± 4.170.5868
 Kidneys5.75 ± 1.565.21 ± 0.780.13466.29 ± 1.510.0002*
 Stomach2.15 ± 0.832.15 ± 0.550.99792.68 ± 0.800.1511
  • * Calculated using Mann–Whitney. P values are with reference to control group of each radiotracer.

  • Data are mean %IA/g ± SD (n = 5–6) 4 h after injection.